JP Morgan Maintains Neutral on Incyte, Raises Price Target to $123

Benzinga Newsdesk www.benzinga.com Positive 60.8%

Neg 0% Neu 0% Pos 60.8%

JP Morgan analyst Jessica Fye maintains Incyte (NASDAQ:INCY) with a Neutral and raises the price target from $120 to $123.